Real world evaluation of lipoprotein (a) testing and impact on LDL-C management in atherosclerotic cardiovascular disease patients: findings from the CVMOBIUS2 registry
Electronic health record data from 17 US health systems between 1/1/2021-12/31/2024 were analyzed to determine the prevalence of Lp(a) testing among adults with ASCVD and changes in LDL-C management in those who are identified to have elevated Lp(a) levels.